GlassScriptPhysician profile
Jason Welter
NPI 1376715144
$14,182.14
in general payments reported to CMS, 2019-2025
15 companies · $3,724 in 2025
The $3,724 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,710 · 2020: $803 · 2021: $906 · 2022: $1,989 · 2023: $1,683 · 2024: $1,367 · 2025: $3,724.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,774.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $4,855.11 | 2019-2025 | Tfn-Advance, Na, Motoband |
| Smith+Nephew, INC. | $2,551.24 | 2019-2023 | Evos, Trigen Intertan |
| Zimmer Biomet Holdings, INC. | $2,435.48 | 2019-2025 | Persona, Rosa, Mymobility Platform |
| Stryker Corporation | $1,563.13 | 2019-2025 | Gamma, Pangea, 1788 |
| Medical Device Business Services, INC. | $1,272.69 | 2019-2023 | Tfn-Advance, Na |
| Davol INC. | $625.49 | 2020-2022 | |
| Heron Therapeutics, INC. | $247.50 | 2021-2022 | |
| Kerecis Limited | $159.27 | 2022 | |
| Becton, Dickinson and Company | $149.17 | 2023 | Arista Ah Flexitip |
| Si-Bone, INC. | $114.98 | 2023 | |
| Bioventus LLC | $111.49 | 2020-2021 | |
| Ferring Pharmaceuticals INC. | $35.46 | 2020 | |
| Pacira Therapeutics, INC. | $26.07 | 2020 | |
| Camber Spine Technologies LLC | $17.70 | 2019 | |
| Legacy Ortho LLC | $17.36 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Welter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.